COVID-19

CTI acquires CRO based in Middle East, Africa

17-Sep-2020 By Jenni Spinner

CTI Clinical Trial and Consulting Services has expanded its global reach by purchasing Clinart, a full-service CRO with precence in the MENA region.

Latest COVID-19 news from the FDA

17-Sep-2020 By Jenni Spinner

The US agency continues to issue advice for life-sciences professionals engaged in work related to the virus, and keep an eye out for fraudulent products.

CPhI shifts from real-world to digital realm

16-Sep-2020 By Jenni Spinner

In the face of the COVID-19 pandemic, CPhI Festival of Pharma organizers have shifted the event online but kept the industry content.

Platform forecasts COVID-19 trial outcomes

15-Sep-2020 By Jenni Spinner

The technology from Opyl uses artificial intelligence to anticipate a COVID-19 treatment, vaccine, diagnostic or device’s chances of success in a study.

Medable: COVID-19 fueling decentralized trial adoption

10-Sep-2020 By Jenni Spinner

The company credits its 400% year-over-year growth to rapid acceleration in adoption of virtual clinical trial technology, due in part to the vlrus.

Cynata Therapeutics kicks off COVID-19 trial enrollment

09-Sep-2020 By Jenni Spinner

The clinical-stage biotech firm is investigating early efficacy of its Cymerus mesenchymal stem cells for treatment of severe COVID-19 patients.

JanOne poised to produce drug for CV, COVID-19 trials

08-Sep-2020 By Jenni Spinner

Partnering with Eurofins, the company has verified the developmental batch of its JAN101, aimed to treat cardiovascular conditions and COVID-19.

FSD Pharma announces Phase II trial for potential COVID-19 treatment

08-Sep-2020 By Jenni Spinner

The company has submitted an investigational new drug application for FSD201, a possible therapy for patients with severe cases of the virus.

COVID-19 treatment study predicts adverse drug events

03-Sep-2020 By Jenni Spinner

Innovative research by Tabula Rasa Healthcare uses simulation technology to analyze potential adverse drug events of potential therapies for the virus.

COVID-19 report shares insights on potential therapies

01-Sep-2020 By Jenni Spinner

A new scientific report offers a comprehensive review of protein targets, associated COVID-19 drug candidates to date and other revealing information.

NIAID awards $44m contract to advance COVID-19 drug

31-Aug-2020 By Jenni Spinner

The US institute has given a new contract to drug developer BioCryst to explore use of galidesivir in treatment of non-hospitalized COVID-19 patients.